Article info
Commentary
Health promotion and public health
Modelling suggests that high human papilloma virus (HPV) vaccination coverage in combination with high uptake screening can lead to cervical cancer elimination in most low-income and lower-middle-income countries (LMICs) by the end of the century
- Correspondence to Professor Saivash Moradi, Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences Faculty of Medicine, Sari, Iran; d.smor86{at}yahoo.com
Citation
Modelling suggests that high human papilloma virus (HPV) vaccination coverage in combination with high uptake screening can lead to cervical cancer elimination in most low-income and lower-middle-income countries (LMICs) by the end of the century
Publication history
- Accepted May 29, 2020
- First published June 19, 2020.
Online issue publication
June 21, 2021
Article Versions
- Previous version (19 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.